Our objective was to evaluate the usefulness of proton magnetic resonance spectroscopy ( 1 H MRS) in categorizing brain tumours. In vivo single-voxel 1 H M...
Our objective was to evaluate the usefulness of proton magnetic resonance spectroscopy (1H MRS) in categorizing brain tumours. In vivo single-voxel 1H MRS ...
Proton ((1)H) magnetic resonance spectroscopy (MRS) is a noninvasive method that can monitor the metabolic changes in most brain diseases. This technique i...
Proton MR spectroscopy (1H-MRS) has been previously performed in Parkinson's disease (PD) and parkinsonian syndromes to evaluate in vivo concentrations of ...
Purpose:To study the features of proton magnetic resonance spectroscopy (1H-MRS) on amyotrophic lateral sclerosis (ALS) and its relation with clinical scal...
We investigated metabolic changes in brain tumours following treatment, using proton magnetic resonance spectroscopy. In meningiomas, effective therapeutic...
Establishing the presence of upper motor neuron (UMN) pathology is essential for an accurate and definite diagnosis of ALS. However, clinical identificatio...
Proton (H-1) magnetic resonance spectroscopy provides a non-invasive and quantitative measure of brain metabolites. Traumatic brain injury impacts cerebral...
Our objective was to evaluate the usefulness of proton magnetic resonance spectroscopy ((1)H MRS) in categorizing brain tumours. In vivo single-voxel (1)H ...
We present a novel method to integrate in vivo nuclear magnetic resonance spectroscopy (MRS) information into the clinical diagnosis of brain tumours. Wate...
Magnetic resonance imaging (MRI) is the most common and well-established imaging modality for evaluation of intracerebral neoplasms, but there are still so...
A study was undertaken to determine if the vascular characteristics measured by dynamic contrast-enhanced magnetic resonance imaging (primarily permeabilit...